卵巣がんの変異過程は,部位特異の免疫回避を促す
Ignacio Vázquez-García1, Florian Uhlitz1, Nicholas Ceglia1
1Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature
|December 14, 2022
まとめ
高度な血清性卵巣がん (HGSOC) は,遺伝子の変異と位置によって異なる進化をします. これらの要因は腫瘍の微小環境に影響し,免疫反応と免疫療法の有効性に影響します.
科学分野:
- 腫瘍学
- ゲノミクス
- 免疫学
背景:
- 高度血清性卵巣がん (HGSOC) は,ゲノム不安定性,異質性,腹膜内伝播によって特徴付けられています.
- HGSOCにおける現在の免疫療法の限られた有効性は,腫瘍の微小環境のドライバーを理解することを必要としています.
研究 の 目的:
- HGSOCにおける変異過程と解剖学的腫瘍部位が免疫状態にどのように影響するかを調査する.
- HGSOCにおける進化的現象分岐と免疫抵抗メカニズムを特定する.
主な方法:
- 全ゲノムシーケンシング,単細胞RNAシーケンシング,デジタル組織病理学,複合免疫光の統合分析.
- 治療前の42人のHGSOC患者の腫瘍部位を分析した.
主要な成果:
- ホモログな再結合欠乏症 (HRD) 腫瘍は炎症信号伝達,免疫編集,HLA多様性喪失,機能不全のCD8+T細胞を示した.
- フォールドバック逆転腫瘍は,免疫抑制性TGFβシグナル伝達,免疫排除,ナイブ/幹細胞および記憶T細胞を示した.
- 腫瘍のフェノタイプは,アネクサとディスタルの腹腔内部部間で有意に変化した.
結論:
- 変異過程と解剖学的部位は,HGSOCの表型分岐と免疫抵抗の重要な決定因子である.
- 発見は,HGSOCのパーソナライズされた免疫療法と早期発見戦略を開発するためのマルチオームデータ基板を提供します.
関連する概念動画
Tumor Immunotherapy
629
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
629
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


